CERLIMA- intimate care gel gel

CERLIMA by

Drug Labeling and Warnings

CERLIMA by is a Otc medication manufactured, distributed, or labeled by Guangzhou Zhongkebaishi Health Industry CO., LTD. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredient(s)

Benzalkonium Bromide 0.09%

Purpose

Antiseptic / Antimicrobial

Use

1.Reduce vaginal microorganisms that may cause odor, discomfort, or imbalance

2.Provides gentle intimate care and temporary relief of mild irritation.

3.For intravaginal and external topical use.

Warnings

For external and intravaginal use only

Do not use

1. if you are pregnant or in gestational periods
2. on scars, eczema, or dermatitis
3. if you have a known allergy to Benzalkonium Bromide or any listed ingredients

WHEN USING

1. After opening the cap, use the product immediately and do not reuse it.

2. avoid contact with eyes; if contact occurs, rinse thoroughly with water
3. mild temporary tingling may occur
2. do not share applicators

STOP USE

1. irritation, rash, red spot or discomfort occurs .

2.abnormal discharge, fever, pelvic pain, or foul odor develops (may be signs ofanother condition requiring medical attention)

KEEP OUT OF REACH OF CHILDREN

If swallowed, get medical help or contact a Poison Control Center Immediately.

Directions

After washing your hands, open the package, remove the cap, and applyit to the intimate area. Discard applicator after one application.

Other information

1. Store at 15-30°C(59-86°F)
2. Avoid freezing

3. Protect from direct sunlight and excessive heat above 40°C (104°F)

Inactive ingredients

1,2-Hexanediol, 1,2-Pentanediol, Betaine, Butylene Glycol, Carbomer,Centella Asiatica Extract, Cnidium Monnieri Extract, Curcumin,Dandelion (Taraxacum Officinale) Extract, Epigallocatechin GallateEGG Grerfar abereIGlee taee'NeovSPerfoY,'SCuferferarin.Baicalensis Root Extract, Tanshinone IA, Triethanolamine.

Package Label - Principal Display Panel

INGREDIENTS AND APPEARANCE

CERLIMA 
intimate care gel gel

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 73813-0001
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZALKONIUM BROMIDE (UNII: 151T1GQ42D) (BENZALKONIUM - UNII:7N6JUD5X6Y)	BENZALKONIUM BROMIDE	0.09 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
CNIDIUM MONNIERI FRUIT OIL (UNII: JK0MS9P8YL)
TANSHINONE IIA (UNII: 4GPC9FQG6L)
1,2-HEXANEDIOL (UNII: TR046Y3K1G)
WATER (UNII: 059QF0KO0R)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
GLYCERIN (UNII: PDC6A3C0OX)
CARBOMER (UNII: 0A5MM307FC)
TRIETHANOLAMINE (UNII: 9O3K93S3TK)
MATRINE (UNII: N390W430AC)
PENTYLENE GLYCOL (UNII: 50C1307PZG)
METHYLPARABEN (UNII: A2I8C7HI9T)
GLYCERYL GLUCOSIDE (UNII: 3297VXM8Z6)
HYDROXYPROPYL BETADEX (UNII: 1I96OHX6EK)
EPIGALLOCATECHIN GALLATE (UNII: BQM438CTEL)
SCUTELLARIA BAICALENSIS WHOLE (UNII: 6YF0M477I5)
CENTELLA ASIATICA (UNII: 7M867G6T1U)
CURCUMIN (UNII: IT942ZTH98)
TARAXACUM OFFICINALE (UNII: 39981FM375)
RESVERATROL (UNII: Q369O8926L)
BETAINE (UNII: 3SCV180C9W)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 73813-0001-2	7 in 1 BOX	01/02/2026
1	NDC: 73813-0001-1	3 g in 1 VIAL; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		01/02/2026

Labeler - Guangzhou Zhongkebaishi Health Industry CO., LTD (554526464)

Establishment
Name	Address	ID/FEI	Business Operations
Guangzhou Zhongkebaishi Health Industry CO., LTD		554526464	manufacture(73813-0001)